Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
09/03/2008
Trade Name:
Valtrex
Generic or Proper Name (*):
valacyclovir
Indications Studied:
Chickenpox; active or at risk for herpes virus infection
Therapeutic Category:
Antiviral
Ages Studied:
1-<18 years
Study #:
3
Study Type:
Safety/Pharmacokinetic/Tolerability
Study Design:
Open Label/Traditional Pharmacokinetic
No Patients:
27
No Centers:
7
No Countries:
4
BPCA(B), PREA(P):
B, P
Asian:
1
Black:
2
Other:
5
White:
19
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
0
Hispanic/Latino:
0
Non-Hispanic/Non Latino:
27
-
-